Amneal Pharmaceuticals, Inc. (AMRX)

Amneal Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,071	2,454	1,861	301	715	675
Market Cap Growth	61.21%	31.88%	517.29%	-57.87%	6.05%	4.38%
Enterprise Value	6,553	5,081	4,434	2,989	3,372	3,471
Last Close Price	12.95	7.92	6.07	1.99	4.79	4.57
PE Ratio	690.00	-	-	-	67.35	7.41
Forward PE	15.46	11.69	11.92	2.71	5.65	7.07
PS Ratio	1.38	0.88	0.78	0.14	0.34	0.34
PB Ratio	-	-55.10	30.35	1.44	1.86	1.89
P/FCF Ratio	16.31	10.45	6.23	18.49	3.75	2.13
P/OCF Ratio	12.42	8.32	5.38	4.63	2.96	1.78
PEG Ratio	-	0.51	0.51	0.18	0.66	2.65
EV/Sales Ratio	2.23	1.82	1.85	1.35	1.61	1.74
EV/EBITDA Ratio	10.51	8.69	8.85	6.79	7.49	9.11
EV/EBIT Ratio	17.10	14.59	16.34	14.94	15.57	23.83
EV/FCF Ratio	26.25	21.64	14.84	183.29	17.67	10.94
Debt / Equity Ratio	-63.68	-58.22	44.87	13.62	7.52	8.41
Debt / EBITDA Ratio	4.17	4.28	5.26	6.15	6.15	7.36
Debt / FCF Ratio	10.76	11.05	9.21	174.50	15.13	9.46
Asset Turnover	0.83	0.80	0.66	0.57	0.53	0.52
Inventory Turnover	3.04	2.98	2.75	2.79	2.67	3.08
Quick Ratio	1.31	0.82	0.87	1.10	1.39	1.49
Current Ratio	2.13	1.41	1.63	1.88	2.25	2.29
Return on Equity (ROE)	-	-881.26%	-36.06%	-85.96%	5.45%	19.50%
Return on Assets (ROA)	6.79%	6.24%	4.67%	3.23%	3.41%	2.37%
Return on Capital (ROIC)	9.12%	8.12%	5.78%	3.95%	4.08%	2.81%
Return on Capital Employed (ROCE)	14.00%	14.70%	10.30%	6.60%	6.60%	4.40%
Earnings Yield	0.14%	-4.76%	-4.51%	-43.12%	1.49%	13.50%
FCF Yield	6.13%	9.57%	16.06%	5.41%	26.68%	47.01%
Buyback Yield / Dilution	-9.44%	-75.42%	-16.69%	0.58%	-1.95%	-12.72%
Total Shareholder Return	-9.44%	-75.42%	-16.69%	0.58%	-1.95%	-12.72%

Updated Oct 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q